GPR84 regulates pulmonary inflammation by modulating neutrophil functions

被引:0
|
作者
Si-wei Wang
Qing Zhang
Dan Lu
You-chen Fang
Xiao-ci Yan
Jing Chen
Zhi-kan Xia
Qian-ting Yuan
Lin-hai Chen
Yang-ming Zhang
Fa-jun Nan
Xin Xie
机构
[1] Chinese Academy of Sciences,State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica
[2] University of Chinese Academy of Sciences,School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study
[3] University of Chinese Academy of Sciences,Shandong Laboratory of Yantai Drug Discovery
[4] Bohai Rim Advanced Research Institute for Drug Discovery,School of Chinese Materia Medica
[5] Nanjing University of Chinese Medicine,undefined
[6] Burgeon Therapeutics Co.,undefined
[7] Ltd.,undefined
来源
关键词
GPR84; acute lung injury; inflammation; neutrophil; ROS; antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
Acute lung injury (ALI) is an acute, progressive hypoxic respiratory failure that could develop into acute respiratory distress syndrome (ARDS) with very high mortality rate. ALI is believed to be caused by uncontrolled inflammation, and multiple types of immune cells, especially neutrophils, are critically involved in the development of ALI. The treatment for ALI/ARDS is very limited, a better understanding of the pathogenesis and new therapies are urgently needed. Here we discover that GPR84, a medium chain fatty acid receptor, plays critical roles in ALI development by regulating neutrophil functions. GPR84 is highly upregulated in the cells isolated from the bronchoalveolar lavage fluid of LPS-induced ALI mice. GPR84 deficiency or blockage significantly ameliorated ALI mice lung inflammation by reducing neutrophils infiltration and oxidative stress. Further studies reveal that activation of GPR84 strongly induced reactive oxygen species production from neutrophils by stimulating Lyn, AKT and ERK1/2 activation and the assembly of the NADPH oxidase. These results reveal an important role of GPR84 in neutrophil functions and lung inflammation and strongly suggest that GPR84 is a potential drug target for ALI.
引用
收藏
页码:1665 / 1675
页数:10
相关论文
共 50 条
  • [31] GRK2 selectively attenuates the neutrophil NADPH-oxidase response triggered by β-arrestin recruiting GPR84 agonists
    Fredriksson, Johanna
    Holdfeldt, Andre
    Martensson, Jonas
    Bjorkman, Lena
    Moller, Thor C.
    Mullers, Erik
    Dahlgren, Claes
    Sundqvist, Martina
    Forsman, Huamei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2022, 1869 (07):
  • [32] GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
    Qing Zhang
    Lin-hai Chen
    Hui Yang
    You-chen Fang
    Si-wei Wang
    Min Wang
    Qian-ting Yuan
    Wei Wu
    Yang-ming Zhang
    Zhan-ju Liu
    Fa-jun Nan
    Xin Xie
    Acta Pharmacologica Sinica, 2022, 43 : 2042 - 2054
  • [33] FATTY ACID RECEPTORS GPR40/GPR84: TWO PROMISING TARGETS IN KIDNEY FIBROSIS
    Gagnon, Lyne
    Leduc, Martin
    Thibodeau, Jean-Francois
    Leblond, Francois A.
    Laurin, Pierre
    Grouix, Brigitte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 2 - 3
  • [34] GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis
    Heba Abdel-Aziz
    Mathias Schneider
    Winfried Neuhuber
    Abdel Meguid Kassem
    Saleem Khailah
    Jürgen Müller
    Hadeel Gamal Eldeen
    Ahmed Khairy
    Mohamed T. Khayyal
    Anastasiia Shcherbakova
    Thomas Efferth
    Gudrun Ulrich-Merzenich
    Molecular Medicine, 2015, 21 : 1011 - 1024
  • [35] GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis
    Abdel-Aziz, Heba
    Schneider, Mathias
    Neuhuber, Winfried
    Kassem, Abdel Meguid
    Khailah, Saleem
    Mueller, Juergen
    Eldeen, Hadeel Gamal
    Khairy, Ahmed
    Khayyal, Mohamed T.
    Shcherbakova, Anastasiia
    Efferth, Thomas
    Ulrich-Merzenich, Gudrun
    MOLECULAR MEDICINE, 2015, 21 : 1011 - 1024
  • [36] GPR84 inhibition as a novel therapeutic approach in IBD: mechanistic and translational studies
    Dupont, S.
    Arijs, I.
    Blanque, R.
    Laukens, D.
    Nys, K.
    Ceccotti, M. C.
    Merciris, D.
    De Vos, S.
    Mate, O.
    Parent, I.
    De Vriendt, V.
    Labeguere, F.
    Galien, R.
    Devos, M.
    Rutgeerts, P.
    Vandeghinste, N.
    Vermeire, S.
    Brys, R.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S92 - S93
  • [37] A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors GPR40 and GPR84
    Gagnon, Lyne
    Leduc, Martin
    Thibodeau, Jean-Francois
    Zhang, Ming-Zhi
    Grouix, Brigitte
    Sarra-Bournet, Francois
    Gagnon, William
    Hince, Kathy
    Tremblay, Mikael
    Geerts, Lilianne
    Kennedy, Christopher R. J.
    Hebert, Richard L.
    Gutsol, Alex
    Holterman, Chet E.
    Kamto, Eldjonai
    Gervais, Liette
    Ouboudinar, Jugurtha
    Richard, Jonathan
    Felton, Alexandra
    Laverdure, Alexandre
    Simard, Jean-Christophe
    Letourneau, Sylvie
    Cloutier, Marie-Pier
    Leblond, Francois A.
    Abbott, Shaun D.
    Penney, Christopher
    Duceppe, Jean-Simon
    Zacharie, Boulos
    Dupuis, Jocelyn
    Calderone, Angelino
    Nguyen, Quang T.
    Harris, Raymond C.
    Laurin, Pierre
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (05): : 1132 - 1148
  • [38] Medium chain triglyceride induced neutrophil activation is not mediated by the pertussis toxin-sensitive G protein coupled receptor GPR84
    Versleijena, M. W.
    van Esterik, J.
    Roelofs, H.
    de Vries, S. E. van Ernst
    Willems, P. H.
    Wanten, G. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A61 - A62
  • [39] GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
    Timmis, Helen
    Van Kaem, Tim
    Desrivot, Julie
    Dupont, Sonia
    Meuleners, Luc
    Beetens, Johan
    Helmer, Eric
    Santermans, Eva
    Huettner, Silke
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (09): : 994 - 1006
  • [40] Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor
    Gaidarov, Ibragim
    Anthony, Todd
    Gatlin, Joel
    Chen, Xiaohua
    Mills, David
    Solomon, Michelle
    Han, Sangdon
    Semple, Graeme
    Unett, David J.
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 185 - 198